| 0 |
Anthelmintic [EPC] |
2 |
0.0007 |
| 1 |
Lipid Emulsion [EPC] |
1 |
0.0004 |
| 2 |
Antifibrinolytic Agent [EPC] |
2 |
0.0002 |
| 3 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
1 |
0.0001 |
| 4 |
Orexin Receptor Antagonist [EPC] |
1 |
0.0001 |
| 5 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
5 |
0.0000 |
| 6 |
Alkylating Drug [EPC] |
10 |
0.0000 |
| 7 |
Sympathomimetic-like Agent [EPC] |
1 |
0.0000 |
| 8 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
3 |
0.0000 |
| 9 |
Purine Antimetabolite [EPC] |
3 |
0.0000 |
| 10 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
1 |
0.0000 |
| 11 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 12 |
Tumor Necrosis Factor Blocker [EPC] |
18 |
0.0000 |
| 13 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
2 |
0.0000 |
| 14 |
Corticosteroid [EPC] |
18 |
0.0000 |
| 15 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 16 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 17 |
Aldosterone Antagonist [EPC] |
2 |
0.0000 |
| 18 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 19 |
Insulin Analog [EPC] |
5 |
0.0000 |
| 20 |
Factor Xa Inhibitor [EPC] |
3 |
0.0000 |
| 21 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 22 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 23 |
Antirheumatic Agent [EPC] |
1 |
0.0000 |
| 24 |
HMG-CoA Reductase Inhibitor [EPC] |
3 |
0.0000 |
| 25 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 26 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 27 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 28 |
Folate Analog Metabolic Inhibitor [EPC] |
3 |
0.0000 |
| 29 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 30 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
8 |
0.0000 |
| 31 |
Dihydropyridine Calcium Channel Blocker [EPC] |
2 |
0.0000 |
| 32 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 33 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Expectorant [EPC] |
1 |
0.0000 |
| 35 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 36 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 37 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 38 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 39 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 40 |
Loop Diuretic [EPC] |
1 |
0.0000 |
| 41 |
Thalidomide Analog [EPC] |
1 |
0.0000 |
| 42 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |
| 43 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |